These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 21595834

  • 1. Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals.
    Ott J, Aust S, Promberger R, Huber JC, Kaufmann U.
    J Sex Med; 2011 Aug; 8(8):2361-9. PubMed ID: 21595834
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
    Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ.
    Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sexual functioning in transsexuals following hormone therapy and genital surgery: a review.
    Klein C, Gorzalka BB.
    J Sex Med; 2009 Nov; 6(11):2922-39; quiz 2940-1. PubMed ID: 20092545
    [Abstract] [Full Text] [Related]

  • 6. Twenty years of endocrinologic treatment in transsexualism: analyzing the role of chromosomal analysis and hormonal profiling in the diagnostic work-up.
    Auer MK, Fuss J, Stalla GK, Athanasoulia AP.
    Fertil Steril; 2013 Oct; 100(4):1103-10. PubMed ID: 23809495
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP, Madison CM, Milne NM.
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [Abstract] [Full Text] [Related]

  • 9. Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.
    Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB.
    Fertil Steril; 2010 Mar 01; 93(4):1267-72. PubMed ID: 19200981
    [Abstract] [Full Text] [Related]

  • 10. Distinctive features of female-to-male transsexualism and prevalence of gender identity disorder in Japan.
    Baba T, Endo T, Ikeda K, Shimizu A, Honnma H, Ikeda H, Masumori N, Ohmura T, Kiya T, Fujimoto T, Koizumi M, Saito T.
    J Sex Med; 2011 Jun 01; 8(6):1686-93. PubMed ID: 21477021
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies.
    Oda H, Kinoshita T.
    BMC Psychiatry; 2017 Jul 17; 17(1):256. PubMed ID: 28716082
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F.
    Maturitas; 2018 Jan 17; 107():92-96. PubMed ID: 29169588
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical management of youth with gender dysphoria in Vancouver.
    Khatchadourian K, Amed S, Metzger DL.
    J Pediatr; 2014 Apr 17; 164(4):906-11. PubMed ID: 24315505
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.